DLD Asset Management LP purchased a new position in Aetna Inc (NYSE:AET) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 3,500 shares of the company’s stock, valued at approximately $631,000. Aetna accounts for 0.0% of DLD Asset Management LP’s holdings, making the stock its 26th largest position.
Other hedge funds and other institutional investors have also modified their holdings of the company. Lloyds Banking Group plc bought a new position in Aetna in the 3rd quarter worth approximately $106,000. Moisand Fitzgerald Tamayo LLC bought a new position in Aetna in the 3rd quarter worth approximately $116,000. Cerebellum GP LLC bought a new position in Aetna in the 4th quarter worth approximately $125,000. Harel Insurance Investments & Financial Services Ltd. bought a new position in Aetna in the 4th quarter worth approximately $180,000. Finally, Signature Estate & Investment Advisors LLC bought a new position in Aetna in the 4th quarter worth approximately $182,000. 84.88% of the stock is currently owned by institutional investors.
Aetna Inc (AET) opened at $175.75 on Tuesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.68 and a quick ratio of 0.53. The company has a market capitalization of $57,394.76, a price-to-earnings ratio of 17.86, a price-to-earnings-growth ratio of 1.42 and a beta of 0.60. Aetna Inc has a one year low of $124.84 and a one year high of $194.40.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, April 12th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date is Wednesday, April 11th. Aetna’s dividend payout ratio is currently 34.78%.
AET has been the topic of several recent analyst reports. Piper Jaffray Companies raised Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target on the stock in a research report on Wednesday, January 3rd. ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Morgan Stanley cut Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price objective on the stock. in a research report on Wednesday, December 20th. Argus cut Aetna from a “buy” rating to a “hold” rating and set a $185.00 price objective on the stock. in a research report on Wednesday, December 6th. Finally, Jefferies Group boosted their price objective on Aetna from $165.00 to $185.00 and gave the company a “hold” rating in a research report on Wednesday, November 1st. Nine investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $189.50.
ILLEGAL ACTIVITY NOTICE: This piece was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3226115/dld-asset-management-lp-invests-631000-in-aetna-inc-aet-stock.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.